Device product
Tosoh ST AIA-PACK HbA1c Pretreatment Solution, HbA1c Pretreatment Solution, PN 025718 The device is intended for In Vitro Diagnostic Use Only for the pretreatment of the patient samples or control set for the HbA1c assay
Z-1812-2018
Product summary
- Event
- Event 79708
- Status
- Terminated
- Classification
- Class II
- Quantity
- 2258
- Official record key
device-enforcement:Z-1812-2018
Official wording
Reason: The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.
Code information: All lots.
Distribution pattern: USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
Derived failure modes
-
Unknown
The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.